Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
CareTrust reports after market close, meaning Day 0 reflects anticipation and any after-hours reaction, while Day +1 captures the first full trading session where investors digest the results and management commentary.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-06 | -$0.01 (-0.02%) | $0.67 (1.63%) | +$0.09 (+0.22%) | $0.77 (1.87%) |
| 2026-05-07 | +$0.02 (+0.05%) | $0.86 (2.18%) | +$2.10 (+5.32%) | $1.47 (3.72%) |
| 2026-02-12 | +$0.75 (+1.90%) | $0.91 (2.30%) | -$0.13 (-0.32%) | $1.28 (3.19%) |
| 2025-11-05 | +$0.61 (+1.72%) | $1.08 (3.04%) | -$0.44 (-1.22%) | $1.50 (4.17%) |
| 2025-08-06 | -$0.14 (-0.43%) | $0.39 (1.19%) | -$0.10 (-0.31%) | $1.60 (4.90%) |
| 2025-05-01 | -$0.20 (-0.68%) | $0.45 (1.53%) | -$0.53 (-1.82%) | $1.70 (5.84%) |
| 2025-02-12 | -$0.17 (-0.66%) | $0.57 (2.21%) | +$0.94 (+3.67%) | $1.45 (5.66%) |
| 2024-10-29 | +$0.61 (+1.95%) | $0.73 (2.33%) | +$0.89 (+2.79%) | $0.98 (3.07%) |
| Avg Abs Move | 0.93% | 2.05% | 1.96% | 4.05% |
Historical price behavior shows moderate volatility around earnings, with the stock averaging a 0.93% absolute move on Day 0 and a larger 1.96% move by Day +1. Intraday ranges are wider, averaging 2.05% on earnings day and 4.05% the following session, indicating that initial reactions can be muted but follow-through tends to be more pronounced.
Recent quarters show a pattern of positive Day 0 reactions followed by mixed Day +1 performance. In Q2 2026 (August), the stock was essentially flat on Day 0 but surged 5.32% the next day—the largest one-day gain in the dataset—suggesting strong management commentary or guidance drove delayed enthusiasm. Q1 2026 (February) saw a 1.90% Day 0 gain that reversed slightly the next session. The most recent comparable quarter (Q3 2025, November) posted a 1.72% Day 0 gain but gave back ground with a 1.22% decline on Day +1.
The data suggests investors should expect a move in the 1-2% range initially, with potential for a 4-5% swing by the end of the following session depending on guidance and management's commentary about the acquisition pipeline and 2027 outlook.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 16) |
| Expected Move | $1.76 (4.63%) |
| Expected Range | $36.21 to $39.73 |
| Implied Volatility | 30.93% |
The options market is pricing a 4.63% expected move by the November 20 expiration, which sits above the historical average Day +1 move of 1.96% but below the average Day +1 intraday range of 4.05%. This suggests options traders are anticipating slightly elevated volatility compared to typical post-earnings behavior, possibly reflecting uncertainty around guidance or the sustainability of the company's acquisition pace. The expected move implies a trading range between $36.21 and $39.73.
Current Analyst Consensus
CareTrust REIT holds a Strong Buy consensus among Wall Street analysts, with 11 Strong Buy ratings, 1 Moderate Buy, and 4 Hold ratings—no analysts recommend selling the stock. The average price target of $43.53 implies 14.7% upside from the current price of $37.95, with estimates ranging from a low of $40.00 to a high of $49.00. This wide range reflects differing views on how much credit to give management for future acquisition opportunities versus execution risk.
Sentiment Shift
Analyst sentiment has deteriorated modestly over the past month, with the average recommendation slipping from 4.53 to 4.44 on the 5-point scale. This subtle downgrade reflects a handful of analysts moving from Strong Buy to Buy or from Buy to Hold as the stock has approached or exceeded some price targets. One month ago, the consensus was slightly more bullish, with 11 Strong Buys, 1 Moderate Buy, and only 3 Holds; the addition of a fourth Hold rating signals growing caution.
What the Consensus Implies
Despite the recent cooling, the analyst community remains overwhelmingly positive on CareTrust's prospects. The 14.7% implied upside to the $43.53 average target suggests the Street believes the company's aggressive capital deployment strategy will continue to drive earnings growth and justify current valuations. However, the deterioration in sentiment and the emergence of additional Hold ratings indicate that some analysts are becoming more selective, likely concerned that the stock's recent run has priced in much of the near-term good news. The high target of $49.00 represents the bull case where acquisition activity accelerates further and integration proceeds smoothly, while the $40.00 low target reflects a more conservative view that competitive pressures and rising leverage could constrain upside.
Barchart Technical Opinion
The Barchart Technical Opinion currently registers a 64% Sell signal, a notable improvement from 100% Sell one week ago and 88% Sell one month ago. This strengthening trend suggests the stock has been stabilizing after a period of technical weakness, though it remains in bearish territory overall. The signal reflects a stock that has been under pressure but is showing signs of finding support.
Timeframe Analysis
Trend Characteristics: The signal shows Average strength with a Weakening direction, suggesting the technical setup is fragile heading into earnings—the stock lacks strong momentum in either direction and recent improvement has been tentative.
Moving Average Analysis
CareTrust is trading above its 5-day ($36.69), 10-day ($36.53), 20-day ($36.38), and 50-day ($37.36) moving averages, indicating short-term support has held. However, the stock remains below both its 100-day ($38.91) and 200-day ($39.00) moving averages, confirming the longer-term downtrend identified by the technical opinion. The current price of $37.95 sits just below the 50-day average, a level that often acts as resistance—breaking cleanly above $38.91 would be needed to shift the intermediate-term picture from bearish to neutral.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $36.69 | 50-Day MA | $37.36 |
| 10-Day MA | $36.53 | 100-Day MA | $38.91 |
| 20-Day MA | $36.38 | 200-Day MA | $39.00 |
The technical setup heading into earnings is mixed: short-term momentum has stabilized with the stock holding above its 20- and 50-day averages, but the failure to reclaim the 100- and 200-day moving averages keeps overhead resistance in place. The 100% long-term Sell signal and the stock's position below $39.00 suggest any rally on strong earnings will face technical headwinds in the $38.91-$39.00 zone. Conversely, a disappointment could quickly test support at the 20-day moving average near $36.38. The improving short-term signals offer some encouragement, but the overall technical picture remains cautious—this is not a stock with strong momentum heading into a catalyst event.